Arnob Banerjee
Impact in
- Immunology top 1%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Hematology top 2%
- Multiple Myeloma Research and Treatments
Papers in
- Hematology 39
- Multiple Myeloma Research and Treatments 37
- Oncology 48
- CAR-T cell therapy research 32
- Peptidase Inhibition and Analysis 8
- Co-authors
- Steven L. ReinerAndrew M. IntlekoferFelix SchambachE. John WherryCaitlin S. DeJongScott M. GordonNaofumi TakemotoSarah M. Russell
- Journals
- Journal of Clinical Oncology (12 papers)HemaSphere (7 papers)Blood (7 papers)The Journal of Immunology (4 papers)Cancer (2 papers)
- Partner nations
- United StatesBelgiumSpain
In The Last Decade
Arnob Banerjee
64 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Immunology 2.0k
- Hematology 582
- Oncology 1.2k
- Cancer Research 220
- Molecular Biology 959
Countries citing papers authored by Arnob Banerjee
This map shows the geographic impact of Arnob Banerjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnob Banerjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnob Banerjee more than expected).
Fields of papers citing papers by Arnob Banerjee
This network shows the impact of papers produced by Arnob Banerjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnob Banerjee. The network helps show where Arnob Banerjee may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Arnob Banerjee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 36 | |
| 3 | 2023 | 28 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 0 | |
| 9 | 2022 | 30 | |
| 10 | 2021 | 34 | |
| 11 | 2021 | 19 | |
| 12 | 2019 | 83 | |
| 13 | 2018 | 11 | |
| 14 | 2017 | 1 | |
| 15 | 2016 | 195 | |
| 16 | 2015 | 19 | |
| 17 | 2008 | 317 | |
| 18 | 2007 | 233 | |
| 19 | Asymmetric T Lymphocyte Division in the Initiation of Adaptive Immune Responses Hit paper breakdown → | 2007 | 643 |
| 20 | 2002 | 58 |
About Arnob Banerjee
Arnob Banerjee is a scholar working on Hematology, Oncology, Immunology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 66 papers that have together received 3.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (37 papers), CAR-T cell therapy research (32 papers), Protein Degradation and Inhibitors (15 papers), Immune Cell Function and Interaction (13 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), Biosimilars and Bioanalytical Methods (11 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Peptidase Inhibition and Analysis (8 papers). The work is most often cited by research in Immunology (2.0k citations), Hematology (582 citations), Oncology (1.2k citations), Cancer Research (220 citations) and Molecular Biology (959 citations). Arnob Banerjee has collaborated with scholars based in United States, Belgium and Spain. Frequent co-authors include Steven L. Reiner, Andrew M. Intlekofer, Felix Schambach, E. John Wherry, Caitlin S. DeJong, Scott M. Gordon, Naofumi Takemoto, Sarah M. Russell, V. Palanivel and Sarah Longworth. Their work appears in journals such as Journal of Clinical Oncology, HemaSphere, Blood, The Journal of Immunology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.